selected publications
-
Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy.
Human gene therapy.
2019
Academic Article
GET IT
Times cited: 4 -
In Vivo Potency Assay for Adeno-Associated Virus-Based Gene Therapy Vectors Using AAVrh.10 as an Example.
Human gene therapy methods.
2018
Academic Article
GET IT
Times cited: 8 -
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2.
Experimental neurology.
2018
Academic Article
GET IT
Times cited: 10 -
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease.
Human gene therapy. Clinical development.
2018
Academic Article
GET IT
Times cited: 91 -
Gene therapy for metachromatic leukodystrophy.
Journal of neuroscience research.
2016
Review
GET IT
Times cited: 62 -
Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.
Pharmacology, biochemistry, and behavior.
2016
Academic Article
GET IT
Times cited: 23 -
Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.
Human gene therapy. Clinical development.
2014
Academic Article
GET IT
Times cited: 50 -
Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.
Human gene therapy. Clinical development.
2014
Academic Article
GET IT
Times cited: 29 -
Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.
Human gene therapy. Clinical development.
2013
Academic Article
GET IT
Times cited: 39 -
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease.
Human gene therapy.
2013
Review
GET IT
Times cited: 19 -
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
Human gene therapy.
2013
Academic Article
GET IT
Times cited: 16 -
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
2013
Academic Article
GET IT
Times cited: 41 -
Safety of direct cardiac administration of AdVEGF-All6A+, a replication-deficient adenovirus vector cDNA/genomic hybrid expressing all three major isoforms of human vascular endothelial growth factor, to the ischemic myocardium of rats.
Human gene therapy. Clinical development.
2013
Academic Article
GET IT
Times cited: 9 -
Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.
Human gene therapy.
2012
Academic Article
GET IT
Times cited: 21 -
AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation.
Science translational medicine.
2012
Academic Article
GET IT
Times cited: 47 -
In vivo gene transfer strategies to achieve partial correction of von Willebrand disease.
Human gene therapy.
2012
Academic Article
GET IT
Times cited: 17 -
AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.
Human gene therapy.
2012
Academic Article
GET IT
Times cited: 38 -
Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
2011
Academic Article
GET IT
Times cited: 74 -
Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.
Molecular therapy : the journal of the American Society of Gene Therapy.
2011
Academic Article
GET IT
Times cited: 56